Cipla invests additional $ 3mn in US’s Chase Pharmaceuticals

By: |
New Delhi | March 16, 2016 12:51 PM

Cipla in May 2014 had invested $1.5 million to acquire 14.6 per cent stake in Chase Pharmaceuticals.

Cipla- Chase dealCipla in May 2014 had invested $1.5 million to acquire 14.6 per cent stake in Chase Pharmaceuticals.. (Reuters photo)

Drug firm Cipla Ltd has made an additional investment of $3 million in US-based Chase Pharmaceuticals engaged in developing novel approaches to improve treatments for Alzheimer’s disease.

The company in May 2014 had invested $1.5 million to acquire 14.6 per cent stake in Chase Pharmaceuticals.

“Cipla (EU) Ltd, UK, a wholly-owned subsidiary of the company…made an additional investment of $3 million in Chase Pharmaceuticals towards full settlement of its obligation under the agreement arrangement for investment in Chase,” Cipla said in a BSE filing.

Consequently, Cipla UK’s total investment in Chase would aggregate to approximately $5.12 million for a 16.7 per cent stake on a fully diluted basis.

As per the agreement in May, Cipla had said it will make an additional $4.5 million investment in Chase upon achievement of certain milestones in this direction.

The investment done through Cipla (EU) Ltd, UK, was part of $21 million syndicate to finance Phase 2a and Phase 2b clinical trials for Chase’s lead drug CPC 201 for treating the disease.

Other investors in the syndicate were Edmond de Rothschild Investment Partners and New Rhein Healthcare LLC.

The original venture funding for Chase was provided by the Brain Trust Accelerator Fund in 2010.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Quarterly Results: Cipla net profit surges 73% to Rs 412 crore in Q4 on robust sales
25G in India: New report suggests 40 million users can take up 5G within first year of service rollout
3Twitter to soon make searching for DMs easier for Android users